SGMO

Sangamo Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

SGMO price

Sangamo Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SGMO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SGMO

Valuation

P/E

Sector -3.50

Industry -3.50

P/BV

Sector 2.01

Industry 2.01

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

0.89

Sector -223.67

Industry -223.67

EV/EBIT

0.86

Sector -47.92

Industry -47.92

P/EBITDA

Sector -21.50

Industry -21.50

P/EBIT

Sector -28.21

Industry -28.21

P/Total Assets

Sector 1.19

Industry 1.19

P/Net Current Assets

0.00

Sector -10.26

Industry -10.26

P/Working Capital

0.00

Sector -167.98

Industry -167.98

EPS

Sector -1.79

Industry -1.79

BVPS

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

Sector 41.30%

Industry 41.30%

EBITDA Margin

-2,157.64%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-2,218.75%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

Sector -35.21%

Industry -35.21%

Net Profit Margins

Sector -35.91%

Industry -35.91%

Asset Turnover

0.02

Sector 0.02

Industry 0.02

Profitability

ROE

Sector -56.67%

Industry -56.67%

ROA

Sector -59.91%

Industry -59.91%

ROIC

-297.76%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.70

Sector 2.89

Industry 2.89

Net Debt / EBITDA

0.89

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

0.86

Sector -8.06

Industry -8.06

Net Debt / Equity

1.46

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

-0.32

Sector 0.46

Industry 0.46

Liabilities/Assets

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-20.77%

Sector -

Industry -

5Y Earnings CAGR

-7.10%

Sector -

Industry -

Fundamentals SGMO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SGMO Sangamo Therapeutics Inc.	$0.00	-100.00%	0.00%	0.00	0.00	0.00%	0.00%
JNJ Johnson & Johnson	$270.61	56.72%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$28.50	26.43%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.75	22.26%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$38.47	-31.25%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$149.22	93.94%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$164.92	11.31%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.81	43.25%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$70.80	-49.40%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$405.08	45.13%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$798.06	38.86%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$114.66	47.81%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$881.77	19.56%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$523.68	37.91%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.25	46.88%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$952.35	29.68%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$41.31	28.80%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SGMO Historical Dividends

current DY: %

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Sangamo Therapeutics

Sangamo Therapeutics Inc.

Average Investor10 user rating

3.0 (2 people)

United States

31 years

Founded: 1995

2000

Time since IPO - 26 years

354

Employees

Sangamo Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-18.95 million.

The company employs approximately 354 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Sangamo Therapeutics Inc. reported $34.56 million in revenue, generating net income of $-123.34 million.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.

The company trades under the ticker SGMO.

Market cap

Net worth

$-18.95 million

$-18,950,000.00

Assets

$59.97 million

$59,970,000.00

Total Shares Outstanding

390.00 million

390,000,000

Average Daily Trading Volume

$10.49 million

$10,486,182.48

Sector

Health Care

Industry

Biotechnology

SGMO

SGMO revenue and profits

Financial Results SGMO

DRAG THE FRAME TO SEE MORE DATA

SGMO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$881.77 16,53% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.25 46,92% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$270.61 56,62% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.75 23,72% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$149.22 94,65% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$164.92 14,08% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$28.50 26,64% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$881.77 16,53% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.25 46,92% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$270.61 56,62% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.75 23,72% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$149.22 94,65% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$164.92 14,08% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$28.50 26,64% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Sangamo Therapeutics (SGMO) today?

The current price of Sangamo Therapeutics (SGMO) is $0.00. The stock began the year trading around $0.42 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Sangamo Therapeutics (SGMO) pay dividends?

Sangamo Therapeutics (SGMO) did not pay dividends over the past year.

Is Sangamo Therapeutics (SGMO) a good investment?

Sangamo Therapeutics (SGMO) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of -%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Sangamo Therapeutics (SGMO) stock?

You can buy Sangamo Therapeutics (SGMO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol SGMO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Sangamo Therapeutics (SGMO) yield today?

Over the past month, Sangamo Therapeutics (SGMO) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of -%.

If you were to purchase 100 shares of Sangamo Therapeutics (SGMO) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

SGMO

Sangamo Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment SGMO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING SGMO WITH OTHER STOCK

current DY: %

5-year average DY: 0.00%

ABOUT Sangamo Therapeutics

Sangamo Therapeutics Inc.

United States

31 years

2000

354

PROFIT X PRICE SGMO

Financial Results SGMO

SGMO cash flow

Asset, Revenue and Profit Growth - SGMO

SGMO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions